With box warnings

Without box warnings

Branded

Generic

2 results

inqovi
(CEDAZURIDINE and DECITABINE)
Taiho Pharmaceutical Co., Ltd.
Usage: INQOVI is indicated for the treatment of adult patients with myelodysplastic syndromes (MDS), including various subtypes and risk groups as per the International Prognostic Scoring System, applicable to both previously treated and untreated cases.
tibsovo
(ivosidenib)
Servier Pharmaceutical LLC
Usage: TIBSOVO is indicated for treating newly diagnosed acute myeloid leukemia (AML) with an IDH1 mutation, relapsed or refractory AML, relapsed or refractory myelodysplastic syndromes (MDS), and previously treated locally advanced or metastatic cholangiocarcinoma with an IDH1 mutation in adults.

Medications for Other Myelodysplastic Syndromes

inqovi